Search - tctmd.com

Displaying 541 - 560 of 1071

Sort: Relevancy | Date

News Daily News

Fibrinolytic Agents for STEMI: Meta-analysis Explores the Differences

Todd Neale

August 18, 2017

News Daily News

PET More Accurate for Diagnosing CAD Than SPECT and CT Angiography: PACIFIC Study

Michael O'Riordan

August 17, 2017

News Daily News

How Alcohol Hurts and Harms: CVD Sweet Spot Confirmed Anew in Large Meta-Analysis

Shelley Wood

August 15, 2017

News Daily News

Early Invasive Strategy Benefits Select High-Risk NSTE ACS Patients, Meta-analysis Suggests

Michael O'Riordan

August 14, 2017

News Daily News

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

L.A. McKeown

August 03, 2017

News Daily News

Genetic Study Supports Link Between Serum Calcium and CAD Risk

Todd Neale

July 26, 2017

News Daily News

Shingles Strongly Tied to Increase in MI and Stroke Risks

Ashley Lyles

July 06, 2017

News Daily News

Poor Prescription Adherence After Acute MI Continues to Vex Researchers

L.A. McKeown

June 30, 2017

News Daily News

Biomedical Research in CVD: More Investment Today Will Yield Long-term Rewards

Caitlin E. Cox

June 29, 2017

News Conference News TVT 2017

Valve Leaflet Thrombosis: Treat It or Leave It Be?

Shelley Wood

June 19, 2017

News Conference News TVT 2017

Mitral Valve Repair Technologies Inch Forward, but Question of Combination Therapy Looms

Shelley Wood

June 15, 2017

News Daily News

Traditional Chinese Medicine May Aid in Prevention of Cardiovascular Disease

L.A. McKeown

June 12, 2017

News Features EuroPCR 2017

Seven Next-Generation Bioresorbable Scaffolds Show Promise but Face Major Hurdles

Yael L. Maxwell

June 01, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2017

Shelley Wood

June 01, 2017

News Daily News

Beta-Blockers Questioned Anew in Post-MI Patients Without Heart Failure

L.A. McKeown

May 31, 2017

News Conference News EuroPCR 2017

Scaffold Thrombosis ‘Unpredictable’ With Absorb: AIDA Analysis

Michael O'Riordan

May 19, 2017

News Conference News EuroPCR 2017

EUROCTO: Revascularization Bests Medical Therapy for Quality of Life in CTO Lesions

Yael L. Maxwell

May 18, 2017

News Conference News SCAI 2017

Minority Women Face 50% Increased Risk of Death/MI After PCI Compared With White Men at 1 Year

L.A. McKeown

May 18, 2017

News Industry News

Micell Technologies Announces MiStent Achieved Primary Endpoint in All-Comers Randomized Clinical Trial Versus Xience

May 16, 2017

News Conference News EuroPCR 2017

iFR and FFR Equally Safe for Deferring Revascularization, Pooled Analysis Shows

Caitlin E. Cox

May 16, 2017

Advertisement

Fibrinolytic Agents for STEMI: Meta-analysis Explores the Differences

PET More Accurate for Diagnosing CAD Than SPECT and CT Angiography: PACIFIC Study

How Alcohol Hurts and Harms: CVD Sweet Spot Confirmed Anew in Large Meta-Analysis

Early Invasive Strategy Benefits Select High-Risk NSTE ACS Patients, Meta-analysis Suggests

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

Genetic Study Supports Link Between Serum Calcium and CAD Risk

Shingles Strongly Tied to Increase in MI and Stroke Risks

Poor Prescription Adherence After Acute MI Continues to Vex Researchers

Biomedical Research in CVD: More Investment Today Will Yield Long-term Rewards

Valve Leaflet Thrombosis: Treat It or Leave It Be?

Mitral Valve Repair Technologies Inch Forward, but Question of Combination Therapy Looms

Traditional Chinese Medicine May Aid in Prevention of Cardiovascular Disease

Seven Next-Generation Bioresorbable Scaffolds Show Promise but Face Major Hurdles

TCTMD’s Top 10 Most Popular Stories for May 2017

Beta-Blockers Questioned Anew in Post-MI Patients Without Heart Failure

Scaffold Thrombosis ‘Unpredictable’ With Absorb: AIDA Analysis

EUROCTO: Revascularization Bests Medical Therapy for Quality of Life in CTO Lesions

Minority Women Face 50% Increased Risk of Death/MI After PCI Compared With White Men at 1 Year

Micell Technologies Announces MiStent Achieved Primary Endpoint in All-Comers Randomized Clinical Trial Versus Xience

iFR and FFR Equally Safe for Deferring Revascularization, Pooled Analysis Shows

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content